ATE89727T1 - Optisch reines dexniguldipin und dessen derivate zur behandlung von tumorerkrankungen.

Optisch reines dexniguldipin und dessen derivate zur behandlung von tumorerkrankungen.

Info

Publication number: ATE89727T1
Authority: AT; Austria
Prior art keywords: dexniguldipine; derivatives; treatment; optically pure; tumor diseases
Prior art date: 1988-02-19

Application number

AT89902511T

Other languages

Inventor

Kurt Klemm

Wolf-Ruediger Ulrich

Dieter Flockerzi

Karl Sanders

Klaus-Dieter Beller

Christian Schudt

Rainer Boer

Klaus Gietzen

Original Assignee

Byk Gulden Lomberg Chem Fab

Priority date

1988-02-19

Filing date

1989-02-16

Publication date

1993-06-15

1989-02-16 Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab

1989-02-16 Priority claimed from EP89902511A external-priority patent/EP0401256B1/de

1993-06-15 Application granted granted Critical

1993-06-15 Publication of ATE89727T1 publication Critical patent/ATE89727T1/de

SVJMLYUFVDMUHP-MGBGTMOVSA-N (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O5-[3-(4,4-diphenyl-1-piperidinyl)propyl] ester O3-methyl ester Chemical compound C1([C@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)OCCCN2CCC(CC2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=CC([N+]([O-])=O)=C1 SVJMLYUFVDMUHP-MGBGTMOVSA-N 0.000 title 1
206010028980 Neoplasm Diseases 0.000 title 1
229950002422 dexniguldipine Drugs 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1

AT89902511T 1988-02-19 1989-02-16 Optisch reines dexniguldipin und dessen derivate zur behandlung von tumorerkrankungen. ATE89727T1 (de)